Christine Galustian

2.7k citations

61 papers · 2.2k indexed · h-index 25

Hematology top 2%
- Multiple Myeloma Research and Treatments 14
Immunology top 5%
- Immune Cell Function and Interaction 16
- Immunotherapy and Immune Responses 13
Oncology top 5%
- CAR-T cell therapy research 8
Immunology and Allergy top 5%
- Cell Adhesion Molecules Research 7
Molecular Biology top 5%
- Glycosylation and Glycoproteins Research 11
- Protein Degradation and Inhibitors 6
Pulmonary and Respiratory Medicine
- Prostate Cancer Treatment and Research 7

Co-authors: Ten Feizi Angus Dalgleish Alexander Lawson Wengang Chai Shigeyuki Fukui B Meyer Jake Y. Henry Prokar Dasgupta
Cited by: Hematology Immunology Oncology
Journals: Journal of Biological Chemistry (1 paper)Angewandte Chemie International Edition (1 paper)Journal of Clinical Oncology (3 papers)
Partner nations: United Kingdom Japan United States

In The Last Decade

Christine Galustian

61 papers receiving 2.2k citations

Peers

Countries citing papers authored by Christine Galustian

Since Specialization

Citations

This map shows the geographic impact of Christine Galustian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Galustian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Galustian more than expected).

Fields of papers citing papers by Christine Galustian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Galustian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Galustian. The network helps show where Christine Galustian may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Christine Galustian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christine Galustian Line = papers co-authored together Christine Galustian links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cyto-IL-15 synergizes with the STING agonist ADU-S100 to eliminate prostate tumors and confer durable immunity in mouse models Frontiers in Immunology ·Efthymia Papaevangelou,Ana M. Esteves,Prokar Dasgupta,Christine Galustian	2023	8
2	Combination of Interleukin-15 With a STING Agonist, ADU-S100 Analog: A Potential Immunotherapy for Prostate Cancer Frontiers in Oncology ·Ana M. Esteves,Efthymia Papaevangelou,Prokar Dasgupta,Christine Galustian	2021	27
3	IL-15 Upregulates Telomerase Expression and Potently Increases Proliferative Capacity of NK, NKT-Like, and CD8 T Cells Frontiers in Immunology ·Fiona Watkinson,Sandeep Krishan Nayar,Aradhana Rani,Christina Sakellariou,Oussama Elhage,Efthymia Papaevangelou,Prokar Dasgupta,Christine Galustian	2021	32
4	King’s Health Partners’ Prostate Cancer Biobank (KHP PCaBB) BMC Cancer ·S. R. Saifuddin,Wout Devlies,Aida Santaolalla,Fidelma Cahill,Gincy George,Deborah Enting,Sarah Rudman,Paul Cathcart,Ben Challacombe,Prokar Dasgupta,Christine Galustian,Ashish Chandra,S. Chowdhury,Cheryl Gillett,Mieke Van Hemelrijck	2017	11
5	Extending the lifespan and efficacies of immune cells used in adoptive transfer for cancer immunotherapies–A review OncoImmunology ·Sandeep Krishan Nayar,Prokar Dasgupta,Christine Galustian	2015	34
6	Expression of IL-15 and IL-2 cytokines and receptors on prostate cancer cells - significance in prostate immunotherapeutics British journal of surgery ·Christina Sakellariou,Christine Galustian,Oussama Elhage,Osamu Ukimura,Inderbir S. Gill,Richard A. Smith,Prokar Dasgupta	2013	2
7	The immunomodulatory drug lenalidomide restores a vitamin D sensitive phenotype to the vitamin D resistant breast cancer cell line MDA-MB-231 through inhibition of BCL-2: potential for breast cancer therapeutics APOPTOSIS ·Carole Brosseau,Kay W. Colston,Angus Dalgleish,Christine Galustian	2011	16
8	Effect of lenalidomide on the antiprostate cancer activity of docetaxel in vitro and in vivo. Journal of Clinical Oncology ·Jake Y. Henry,Lingeng Lu,Mark E. Adams,Britta Meyer,J. Blake Bartlett,Christine Galustian,Angus Dalgleish	2010	1
9	The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells Cancer Immunology Immunotherapy ·Christine Galustian,B Meyer,Marie‐Christine Labarthe,Keith Dredge,Deborah Klaschka,Jake Y. Henry,Stephen Todryk,Roger Chen,George W. Muller,David Stirling,Peter Schäfer,J. Blake Bartlett,Angus Dalgleish	2008	324
10	Impact of surgery on immunologic function: comparison between minimally invasive techniques and conventional laparotomy for surgical resection of colorectal tumors The American Journal of Surgery ·Charles Evans,Christine Galustian,Devinder Kumar,R Hagger,David M. Melville,Mark Bodman‐Smith,Ian Jourdan,A. M. Gudgeon,Angus Dalgleish	2008	60
11	Thalidomide-derived immunomodulatory drugs as therapeutic agents Expert Opinion on Biological Therapy ·Christine Galustian,Marie‐Christine Labarthe,J. Blake Bartlett,Angus Dalgleish	2004	35
12	Interactions of the gastrotropic bacteriumHelicobacter pyloriwith the leukocyteâendothelium adhesion molecules, the selectins â a preliminary report FEMS Immunology & Medical Microbiology ·Christine Galustian,Nicola Elviss,Henrik Chart,Robert J. Owen,Ten Feizi	2003	23
13	Synergistic interactions of the two classes of ligand, sialyl‐Lewis^a/x fuco‐oligosaccharides and short sulpho‐motifs, with the P‐ and L‐selectins: implications for therapeutic inhibitor designs Immunology ·Christine Galustian,Robert A. Childs,Mark S. Stoll,Hideharu Ishida,Makoto Kiso,Ten Feizi	2002	31
14	Oligosaccharide microarrays for high-throughput detection and specificity assignments of carbohydrate-protein interactions Nature Biotechnology ·Shigeyuki Fukui,Ten Feizi,Christine Galustian,Alexander Lawson,Wengang Chai	2002	469
15	Transcription Factor NFκB Expression and Postsurgical Organ Dysfunction Annals of Surgery ·Sharmila Foulds,Christine Galustian,Averil O. Mansfield,Michael Schächter	2001	33
16	The First Total Synthesis of 6-Sulfo-de-N-acetylsialyl Lewisx Ganglioside: A Superior Ligand for Human L-Selectin Angewandte Chemie International Edition ·Shiro Komba,Christine Galustian,H. Ishida,Ten Feizi,Reiji Kannagi,Makoto Kiso	1999	62
17	Recombinant Soluble Human CD69 Dimer Produced in Escherichia coli: Reevaluation of Saccharide Binding Biochemical and Biophysical Research Communications ·Robert A. Childs,Christine Galustian,Alexander Lawson,Gordon Dougan,Karen Benwell,Gad Frankel,Ten Feizi	1999	13
18	L-selectin Interactions with Novel Mono- and Multisulfated Lewisx Sequences in Comparison with the Potent Ligand 3′-Sulfated Lewisa Journal of Biological Chemistry ·Christine Galustian,André Lubineau,Christine Le Narvor,Makoto Kiso,Gavin M. Brown,Ten Feizi	1999	37
19	Novel oligosaccharide ligands and ligand-processing pathways for the selectins Trends in Biochemical Sciences ·Ten Feizi,Christine Galustian	1999	24
20	Sialyl-LewisxSequence 6-O-Sulfated atN-Acetylglucosamine Rather Than at Galactose Is the Preferred Ligand forl-Selectin and De-N-acetylation of the Sialic Acid Enhances the Binding Strength Biochemical and Biophysical Research Communications ·Christine Galustian,Alexander Lawson,Shiro Komba,Hideharu Ishida,Makoto Kiso,Ten Feizi	1997	73

About Christine Galustian

Christine Galustian is a scholar working on Hematology, Immunology and Immunology and Allergy, having authored 61 papers that have together received 2.2k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (16 papers), Multiple Myeloma Research and Treatments (14 papers), Immunotherapy and Immune Responses (13 papers), Glycosylation and Glycoproteins Research (11 papers), CAR-T cell therapy research (8 papers), Cell Adhesion Molecules Research (7 papers), Prostate Cancer Treatment and Research (7 papers) and Protein Degradation and Inhibitors (6 papers). The work is most often cited by research in Hematology (387 citations), Immunology (719 citations) and Oncology (573 citations). Christine Galustian has collaborated with scholars based in United Kingdom, Japan and United States. Frequent co-authors include Ten Feizi, Angus Dalgleish, Alexander Lawson, Wengang Chai, Shigeyuki Fukui, B Meyer, Jake Y. Henry, Prokar Dasgupta, Marie‐Christine Labarthe and J. Blake Bartlett. Their work appears in journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact